Lasa Supergenerics Ltd (LASA) is currently trading at 9.35 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Lasa Supergenerics Limited is engaged in manufacturing, trading, and producing chemicals, pharmaceuticals, and veterinary APIs, with comprehensive capabilities in research, production, and marketing. The company specializes in catalyst chemistry and is among India's largest producers of anthelmintic and veterinary API products, with significant production capacity at its facilities in Maharashtra. Lasa's strategic amalgamation with Harishree Aromatics and Chemicals Pvt. Ltd. strengthens its manufacturing capabilities and market reach, approved by the National Company Law Tribunal in late 2022. The company has launched two new high-demand veterinary products and is expanding capacity at its Chiplun unit, aiming to capture significant market share globally. With a WHO Certificate of Good Manufacturing Practices, Lasa is positioned as a key player in the animal healthcare sector with robust global alliances.

Over the past 52 weeks, Lasa Supergenerics Ltd has traded between a low of ₹8.21 and a high of ₹27.25. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Lasa Supergenerics Ltd has a market capitalization of approximately 47.10. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Lasa Supergenerics Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 94.00 and operates in the Pharmaceuticals sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

You can buy shares of Lasa Supergenerics Ltd (LASA) through any SEBI-registered stockbroker in India. A demat and trading account are required to place buy or sell orders on stock exchanges such as NSE or BSE. Shares are credited to the demat account as per the exchange settlement cycle.

Based on its market capitalization of 47.10 Cr, Lasa Supergenerics Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Lasa Supergenerics Ltd operates in the Pharmaceuticals sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Lasa Supergenerics Ltd is 94.00. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Lasa Supergenerics Ltd currently does not pay dividends. Companies that do not pay dividends often reinvest profits to support business growth or strengthen operations.

Key risks associated with Lasa Supergenerics Ltd include sector-specific challenges in the Pharmaceuticals industry, regulatory changes, competitive pressures, company-level financial performance, overall market volatility, and broader macroeconomic factors that can impact stock prices.